|
|
||||||||
News in Physiological Sciences, Vol 12, 263-268, Copyright © 1997 by International Union of Physiological Sciences
ARTICLES |
F Benedetti
Several lines of evidence indicate that cholecystokinin (CCK) antagonists potentiate analgesia induced by exogenous opioids. Similarly, CCK antagonists enhance analgesia induced by procedures that activate endogenous opioid systems. However, because there are substantial species differences in receptor specificity and distribution, the role of CCK type A and type B receptors has yet to be clearly established.
This article has been cited by other articles:
![]() |
F. Benedetti, M. Amanzio, S. Vighetti, and G. Asteggiano The Biochemical and Neuroendocrine Bases of the Hyperalgesic Nocebo Effect. J. Neurosci., November 15, 2006; 26(46): 12014 - 12022. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Benedetti How the Doctor's Words Affect the Patient's Brain Eval Health Prof, December 1, 2002; 25(4): 369 - 386. [Abstract] [PDF] |
||||
![]() |
S. Bhatnagar, V. Viau, A. Chu, L. Soriano, O. C. Meijer, and M. F. Dallman A Cholecystokinin-Mediated Pathway to the Paraventricular Thalamus Is Recruited in Chronically Stressed Rats and Regulates Hypothalamic-Pituitary-Adrenal Function J. Neurosci., July 15, 2000; 20(14): 5564 - 5573. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |